VIDEO: Looking ahead to ASH 2021

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Although we just finished the ASH 2020 Annual Meeting, it's never too early to start looking ahead to what may be coming out later this year. It seems that every year, ASH sneaks up quicker and quicker, and the pace of research just continues unabated. Some of the things that I'm really looking forward to learning more about this year would be getting some additional data for CAR T-cell therapy in lymphomas. There are a number of novel constructs that are currently under investigation, and I hope that we'll continue to learn more about those in identifying when those can potentially be utilized versus our currently available CAR T-cell constructs. I also am, from the standpoint of my own research, I'm excited to learn more about the use of novel therapies in Mantle cell lymphoma, especially in the frontline setting. There's been a number of studies that have been ongoing, utilizing BTK inhibitors and other agents in the frontline setting, and I'm hopeful that this year we'll hear more about some of those studies that will help us inform treatment options for those patients.